Drug‐Induced Raynaud's Phenomenon and Underlying Mechanism: A Disproportionality Analysis From the World Health Organization Pharmacovigilance Database
This study allowed us to identify robust safety signals (such as solriamfetol, tyrosine kinase inhibitors, and calcitonin gene-related peptide inhibitors) for drugs associated with RP and potential implicated pathophysiologic mechanisms.
Authors
- Matthieu Roustit (ORCID: https://orcid.org/0000-0003-4475-1626)
- Loubna Dari (ORCID: https://orcid.org/0000-0001-6759-4980)
- Charles Khouri (ORCID: https://orcid.org/0000-0002-8427-8573)
- Alex Hlavaty (ORCID: https://orcid.org/0009-0002-8483-5023)
- Jean‐Luc Cracowski (ORCID: https://orcid.org/0000-0003-0787-1469)
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Health First (US)
- Bordeaux Population Health (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1002/art.43442
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31